Fuzzy Sugeno integral interpretation with application in histopathology image analysis

[1]  William M Gallagher,et al.  Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer , 2008, Breast Cancer Research.

[2]  Kyle J. Myers,et al.  Automated Quantitative Assessment of HER-2/neu Immunohistochemical Expression in Breast Cancer , 2009, IEEE Transactions on Medical Imaging.

[3]  N. Otsu A threshold selection method from gray level histograms , 1979 .

[4]  Lotfi A. Zadeh,et al.  Fuzzy Sets , 1996, Inf. Control..

[5]  Anant Madabhushi,et al.  Automated grading of breast cancer histopathology using spectral clustering with textural and architectural image features , 2008, 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[6]  James M. Keller,et al.  Applications of Fuzzy Logic in Bioinformatics , 2008, Series on Advances in Bioinformatics and Computational Biology.

[7]  N. Robert,et al.  Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Zheru Chi,et al.  Image retrieval based on Sugeno fuzzy integral , 2004, Third International Conference on Image and Graphics (ICIG'04).

[9]  J. Baak,et al.  Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer , 2007, Journal of Clinical Pathology.

[10]  A. Madabhushi,et al.  Histopathological Image Analysis: A Review , 2009, IEEE Reviews in Biomedical Engineering.

[11]  C. Vogel,et al.  Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. , 2005, Clinical breast cancer.